Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) CAO Ryan M. Bartolucci sold 6,059 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The shares were sold at an average price of $80.00, for a total value of $484,720.00. Following the sale, the chief accounting officer now owns 47,000 shares in the company, valued at $3,760,000. The trade was a 11.42 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Tempus AI Price Performance
TEM opened at $89.44 on Monday. The stock’s 50 day moving average price is $46.60 and its 200 day moving average price is $50.37. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.
Analysts Set New Price Targets
Several research firms recently issued reports on TEM. Guggenheim assumed coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 price target on the stock. Bank of America increased their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. TD Cowen reaffirmed a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Wolfe Research initiated coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock. Finally, Piper Sandler restated a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Four analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of TEM. Comerica Bank lifted its holdings in Tempus AI by 342.5% in the fourth quarter. Comerica Bank now owns 112,145 shares of the company’s stock worth $3,786,000 after purchasing an additional 86,800 shares during the period. Tudor Investment Corp ET AL acquired a new stake in shares of Tempus AI in the 4th quarter worth approximately $348,000. Mission Creek Capital Partners Inc. bought a new position in shares of Tempus AI in the fourth quarter valued at approximately $1,612,000. Oxford Asset Management LLP acquired a new position in shares of Tempus AI during the fourth quarter valued at approximately $457,000. Finally, Gilder Gagnon Howe & Co. LLC bought a new stake in Tempus AI during the fourth quarter worth approximately $775,000. 24.22% of the stock is owned by institutional investors and hedge funds.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
- Five stocks we like better than Tempus AI
- What is a Death Cross in Stocks?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How to Effectively Use the MarketBeat Ratings Screener
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.